Results 211 to 220 of about 124,881 (307)

Transient Global Amnesia After Screening Esophagogastroduodenoscopy: Incidence and Risk Factors in a 20‐Year Single‐Center Cohort

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Background and Aim Transient global amnesia (TGA) after esophagogastroduodenoscopy (EGD) has been described only in case reports. Because sudden‐onset amnesia can mimic stroke and other acute central nervous system disorders, TGA requires careful differentiation in the acute setting, and clinicians need to be familiar with this condition.
Miyuki Kobayashi   +12 more
wiley   +1 more source

Frailty and Recurrent Cardiovascular Events in Patients With Obstructive Sleep Apnoea: The SAVE Study

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 2, April 2026.
ABSTRACT Background Frailty is a common syndrome in patients with cardiovascular disease (CVD). Whether frailty modifies the risk of recurrent cardiovascular events in patients with established CVD and obstructive sleep apnoea (OSA) is uncertain. We aimed to determine associations of frailty and the risk of recurrent cardiovascular events in adults ...
Shoujiang You   +16 more
wiley   +1 more source

Neuroprotective Effect of Remote Ischemic Conditioning on Patients Undergoing Intravenous Thrombolysis: A Randomized Controlled Trial

open access: yesMedComm, Volume 7, Issue 4, April 2026.
Adjunctive remote ischemic conditioning (RIC) administered twice within 24 h after intravenous thrombolysis (IVT) improved cerebral autoregulation, suggesting that RIC exerted neuroprotective effects in patients undergoing IVT. ABSTRACT Intravenous thrombolysis (IVT) is the treatment with the highest level of evidence for acute ischemic stroke, but ...
Shuang Qi   +11 more
wiley   +1 more source

Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 2, Page 259-271, April 2026.
ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley   +1 more source

Home - About - Disclaimer - Privacy